89 related articles for article (PubMed ID: 27734379)
21. N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan.
Aoyama E; Hattori T; Hoshijima M; Araki D; Nishida T; Kubota S; Takigawa M
Biochem J; 2009 May; 420(3):413-20. PubMed ID: 19298220
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
23. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
[TBL] [Abstract][Full Text] [Related]
24. CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway.
Tzeng HE; Chen JC; Tsai CH; Kuo CC; Hsu HC; Hwang WL; Fong YC; Tang CH
J Cell Physiol; 2011 Dec; 226(12):3181-9. PubMed ID: 21344378
[TBL] [Abstract][Full Text] [Related]
25. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
26. Role of CCN2 in Amino Acid Metabolism of Chondrocytes.
Murase Y; Hattori T; Aoyama E; Nishida T; Maeda-Uematsu A; Kawaki H; Lyons KM; Sasaki A; Takigawa M; Kubota S
J Cell Biochem; 2016 Apr; 117(4):927-37. PubMed ID: 26364758
[TBL] [Abstract][Full Text] [Related]
27. CCN family 2/connective tissue growth factor (CCN2/CTGF) regulates the expression of Vegf through Hif-1alpha expression in a chondrocytic cell line, HCS-2/8, under hypoxic condition.
Nishida T; Kondo S; Maeda A; Kubota S; Lyons KM; Takigawa M
Bone; 2009 Jan; 44(1):24-31. PubMed ID: 18835464
[TBL] [Abstract][Full Text] [Related]
28. CCN3, a key matricellular protein, distinctly inhibits TGFβ1-mediated Smad1/5/8 signalling in human podocyte culture.
Madne TH; Dockrell MEC
Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):5-10. PubMed ID: 29506624
[TBL] [Abstract][Full Text] [Related]
29. Cell Biological Assays for Measuring Chondrogenic Activities of CCN2 Protein.
Nishida T; Kubota S; Takigawa M
Methods Mol Biol; 2017; 1489():219-237. PubMed ID: 27734380
[TBL] [Abstract][Full Text] [Related]
30. Regulation of chondrocytic phenotype by micro RNA 18a: involvement of Ccn2/Ctgf as a major target gene.
Ohgawara T; Kubota S; Kawaki H; Kondo S; Eguchi T; Kurio N; Aoyama E; Sasaki A; Takigawa M
FEBS Lett; 2009 Mar; 583(6):1006-10. PubMed ID: 19233176
[TBL] [Abstract][Full Text] [Related]
31. CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma.
Jia Q; Xue T; Zhang Q; Cheng W; Zhang C; Ma J; Bu Y; Yu S; Liu Q
Sci Rep; 2017 Oct; 7(1):13846. PubMed ID: 29061995
[TBL] [Abstract][Full Text] [Related]
32. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
[TBL] [Abstract][Full Text] [Related]
33. CCN2 as a novel molecule supporting energy metabolism of chondrocytes.
Maeda-Uematsu A; Kubota S; Kawaki H; Kawata K; Miyake Y; Hattori T; Nishida T; Moritani N; Lyons KM; Iida S; Takigawa M
J Cell Biochem; 2014 May; 115(5):854-65. PubMed ID: 24288211
[TBL] [Abstract][Full Text] [Related]
34. The Bone Regeneration Model and Primary Osteoblastic Cell Culture Used in the Analysis of Ccn3 Transgenic and Knockout Mice.
Sakamoto K; Matsushita Y; Minamizato T; Katsuki Y; Katsube KI; Yamaguchi A
Methods Mol Biol; 2017; 1489():309-324. PubMed ID: 27734386
[TBL] [Abstract][Full Text] [Related]
35. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration.
Shimoyama T; Hiraoka S; Takemoto M; Koshizaka M; Tokuyama H; Tokuyama T; Watanabe A; Fujimoto M; Kawamura H; Sato S; Tsurutani Y; Saito Y; Perbal B; Koseki H; Yokote K
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):675-82. PubMed ID: 20139355
[TBL] [Abstract][Full Text] [Related]
36. CCN2 in Skin Fibrosis.
Leask A
Methods Mol Biol; 2017; 1489():417-421. PubMed ID: 27734393
[TBL] [Abstract][Full Text] [Related]
37. CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway.
Chen PC; Cheng HC; Tang CH
Carcinogenesis; 2013 Jul; 34(7):1669-79. PubMed ID: 23536580
[TBL] [Abstract][Full Text] [Related]
38. Altered expression of the CCN genes in the lungs of mice in response to cigarette smoke exposure and viral and bacterial infections.
Gueugnon F; Thibault VC; Kearley J; Petit-Courty A; Vallet A; Guillon A; Si-Tahar M; Humbles AA; Courty Y
Gene; 2016 Jul; 586(1):176-83. PubMed ID: 27080955
[TBL] [Abstract][Full Text] [Related]
39. Role of mechanical-stress inducible protein Hcs24/CTGF/CCN2 in cartilage growth and regeneration: mechanical stress induces expression of Hcs24/CTGF/CCN2 in a human chondrocytic cell line HCS-2/8, rabbit costal chondrocytes and meniscus tissue cells.
Nishida T; Maeda A; Kubota S; Takigawa M
Biorheology; 2008; 45(3-4):289-99. PubMed ID: 18836231
[TBL] [Abstract][Full Text] [Related]
40. Expression and roles of CCN2 in dental epithelial cells.
Shimo T; Koyama E; Kurio N; Matsumoto K; Okui T; Ibaragi S; Yoshioka N; Sasaki A
In Vivo; 2015; 29(2):189-95. PubMed ID: 25792645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
